108 results
Page 4 of 6
8-K
EX-99.1
t1ug7l1wcjl7fs3zin7
8 Nov 19
Recro Pharma Reports Third Quarter 2019 Financial Results
7:05am
8-K
EX-99.1
ot7ywn
31 Oct 19
Other Events
10:10am
8-K
EX-99.2
0pi83zcshe
8 Aug 19
Recro Pharma Reports Second Quarter 2019 Financial Results
7:58am
8-K
EX-99.1
29ranxr
8 Aug 19
Recro Pharma Reports Second Quarter 2019 Financial Results
7:58am
8-K
EX-99.1
0o2rvl s9kph9ucni1oc
20 May 19
Other Events
8:52am
8-K
EX-99.1
hupi39bt0fc3zmi
10 May 19
Recro Pharma Reports First Quarter 2019 Financial Results
7:05am
8-K
EX-99.1
a35uv 33h
5 Apr 19
Cost Associated with Exit or Disposal Activities
4:01pm
8-K
EX-99.1
azxla5pz
28 Mar 19
Recro Pharma Appoints Arnaud Ajdler to Its Board of Directors
6:05am
8-K
EX-99.2
36ng3rsgucz0hu5
19 Feb 19
Recro Pharma Reports Financial Results for the Fourth Quarter and Year End 2018
7:05am
8-K
EX-99.1
vxpa6v95
19 Feb 19
Recro Pharma Reports Financial Results for the Fourth Quarter and Year End 2018
7:05am
8-K
EX-99.1
o7mud
7 Jan 19
Other Events
7:01am
8-K
EX-99.1
77zqe 22c
10 Dec 18
Other Events
2:07pm
8-K
EX-99.1
fmzwhh7e
7 Nov 18
Recro Pharma Reports Third Quarter 2018 Financial Results
7:06am
8-K
EX-99.2
4qg53g9 6mi2xltsz
7 Nov 18
Recro Pharma Reports Third Quarter 2018 Financial Results
7:06am
8-K
EX-99.1
pllje
9 Oct 18
Recro Pharma Announces PDUFA Date for IV Meloxicam
6:07am